197 related articles for article (PubMed ID: 25894266)
1. [Glycation of lens proteins in diabetes and its non-invasive assessment - first experience in the Czech Republic].
Škrha J; Šoupal J; Prázný M; Škrha J
Vnitr Lek; 2015 Apr; 61(4):346-50. PubMed ID: 25894266
[TBL] [Abstract][Full Text] [Related]
2. Autofluorescence of Skin Advanced Glycation End Products: Marker of Metabolic Memory in Elderly Population.
Rajaobelina K; Cougnard-Gregoire A; Delcourt C; Gin H; Barberger-Gateau P; Rigalleau V
J Gerontol A Biol Sci Med Sci; 2015 Jul; 70(7):841-6. PubMed ID: 25589479
[TBL] [Abstract][Full Text] [Related]
3. Skin autofluorescence and the complexity of complications in patients with type 2 diabetes mellitus: a cross-sectional study.
Wang X; Zhao X; Lian T; Wei J; Yue W; Zhang S; Chen Q
BMC Endocr Disord; 2021 Apr; 21(1):58. PubMed ID: 33794864
[TBL] [Abstract][Full Text] [Related]
4. Association between habitual dietary and lifestyle behaviours and skin autofluorescence (SAF), a marker of tissue accumulation of advanced glycation endproducts (AGEs), in healthy adults.
Kellow NJ; Coughlan MT; Reid CM
Eur J Nutr; 2018 Sep; 57(6):2209-2216. PubMed ID: 28656390
[TBL] [Abstract][Full Text] [Related]
5. Advanced glycation end products (AGEs) estimated by skin autofluorescence are related with cardiovascular risk in renal transplant.
Calviño J; Cigarran S; Gonzalez-Tabares L; Menendez N; Latorre J; Cillero S; Millan B; Cobelo C; Sanjurjo-Amado A; Quispe J; Garcia-Enriquez A; Carrero JJ
PLoS One; 2018; 13(8):e0201118. PubMed ID: 30067789
[TBL] [Abstract][Full Text] [Related]
6. Skin autofluorescence predicts major adverse cardiovascular events in patients with type 1 diabetes: a 7-year follow-up study.
Blanc-Bisson C; Velayoudom-Cephise FL; Cougnard-Gregoire A; Helmer C; Rajaobelina K; Delcourt C; Alexandre L; Blanco L; Mohammedi K; Monlun M; Rigalleau V
Cardiovasc Diabetol; 2018 Jun; 17(1):82. PubMed ID: 29884175
[TBL] [Abstract][Full Text] [Related]
7. Assessment of Skin Autofluorescence and Its Association with Glycated Hemoglobin, Cardiovascular Risk Markers, and Concomitant Chronic Diseases in Children with Type 1 Diabetes.
Jankowska M; Szadkowska A; Pietrzak I; Chrzanowski J; Sołek J; Fendler W; Mianowska B
Nutrients; 2024 Jun; 16(12):. PubMed ID: 38931293
[TBL] [Abstract][Full Text] [Related]
8. Advanced glycation end products, measured in skin, vs. HbA1c in children with type 1 diabetes mellitus.
Banser A; Naafs JC; Hoorweg-Nijman JJ; van de Garde EM; van der Vorst MM
Pediatr Diabetes; 2016 Sep; 17(6):426-32. PubMed ID: 26332801
[TBL] [Abstract][Full Text] [Related]
9. Advanced Glycation Endproducts as Biomarkers for Risk of Diabetes and Cardiovascular Diseases by Skin Autofluorescence: A Noninvasive Optical Screening.
Paolillo FR; Mattos VS; Borghi-Silva A; Bagnato VS; de Castro Neto JC
Photobiomodul Photomed Laser Surg; 2019 Mar; 37(3):168-174. PubMed ID: 31050947
[No Abstract] [Full Text] [Related]
10. Reference values for the Chinese population of skin autofluorescence as a marker of advanced glycation end products accumulated in tissue.
Yue X; Hu H; Koetsier M; Graaff R; Han C
Diabet Med; 2011 Jul; 28(7):818-23. PubMed ID: 21204956
[TBL] [Abstract][Full Text] [Related]
11. Skin autofluorescence Is associated With low bone mineral density in type 2 diabetic patients.
Yavuz DG; Apaydin T
J Clin Densitom; 2022; 25(3):373-379. PubMed ID: 34933784
[TBL] [Abstract][Full Text] [Related]
12. Skin autofluorescence in children with and without obesity.
Lentferink YE; van Teeseling L; Knibbe CAJ; van der Vorst MMJ
J Pediatr Endocrinol Metab; 2019 Jan; 32(1):41-47. PubMed ID: 30530882
[TBL] [Abstract][Full Text] [Related]
13. Association of advanced glycation end products, evaluated by skin autofluorescence, with lifestyle habits in a general Japanese population.
Isami F; West BJ; Nakajima S; Yamagishi SI
J Int Med Res; 2018 Mar; 46(3):1043-1051. PubMed ID: 29322837
[TBL] [Abstract][Full Text] [Related]
14. Skin autofluorescence, a non-invasive marker of advanced glycation end products: clinical relevance and limitations.
Da Moura Semedo C; Webb M; Waller H; Khunti K; Davies M
Postgrad Med J; 2017 May; 93(1099):289-294. PubMed ID: 28143896
[TBL] [Abstract][Full Text] [Related]
15. Skin autofluorescence corresponds to microvascular reactivity in diabetes mellitus.
Škrha J; Horová E; Šoupal J; Valeriánová A; Malík J; Prázný M; Zima T; Kalousová M; Škrha J
J Diabetes Complications; 2022 Jul; 36(7):108206. PubMed ID: 35644724
[TBL] [Abstract][Full Text] [Related]
16. Lifestyle and clinical determinants of skin autofluorescence in a population-based cohort study.
van Waateringe RP; Slagter SN; van der Klauw MM; van Vliet-Ostaptchouk JV; Graaff R; Paterson AD; Lutgers HL; Wolffenbuttel BH
Eur J Clin Invest; 2016 May; 46(5):481-90. PubMed ID: 27002914
[TBL] [Abstract][Full Text] [Related]
17. Relationship between cardiac tissue glycation and skin autofluorescence in patients with coronary artery disease.
Hofmann B; Jacobs K; Navarrete Santos A; Wienke A; Silber RE; Simm A
Diabetes Metab; 2015 Nov; 41(5):410-5. PubMed ID: 25553578
[TBL] [Abstract][Full Text] [Related]
18. Increased skin autofluorescence of children and adolescents with type 1 diabetes despite a well-controlled HbA1c: results from a cohort study.
van der Heyden JC; Birnie E; Mul D; Bovenberg S; Veeze HJ; Aanstoot HJ
BMC Endocr Disord; 2016 Sep; 16(1):49. PubMed ID: 27613110
[TBL] [Abstract][Full Text] [Related]
19. Skin autofluorescence of advanced glycation end-products relates to new cardiovascular events in type 2 diabetes: A longitudinal observational study.
Alkhami F; Borderie G; Foussard N; Larroumet A; Blanco L; Barbet-Massin MA; Ferriere A; Ducos C; Mohammedi K; Fawaz S; Couffinhal T; Rigalleau V
Diabetes Metab; 2024 Mar; 50(2):101524. PubMed ID: 38346471
[TBL] [Abstract][Full Text] [Related]
20. Association between the tissue accumulation of advanced glycation end products and exercise capacity in cardiac rehabilitation patients.
Kunimoto M; Shimada K; Yokoyama M; Matsubara T; Aikawa T; Ouchi S; Shimizu M; Fukao K; Miyazaki T; Kadoguchi T; Fujiwara K; Abulimiti A; Honzawa A; Yamada M; Shimada A; Yamamoto T; Asai T; Amano A; Smit AJ; Daida H
BMC Cardiovasc Disord; 2020 Apr; 20(1):195. PubMed ID: 32326893
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
